{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:13:58Z","timestamp":1791846838108,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clnu.2023.12.008","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T22:08:06Z","timestamp":1702332486000},"page":"366-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ceramide enhanced the hepatic glucagon response through regulation of CREB activity"],"prefix":"10.1016","volume":"43","author":[{"given":"Jizheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbao","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-4469","authenticated-orcid":false,"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clnu.2023.12.008_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.clnu.2023.03.014","article-title":"Food addiction is strongly associated with type 2 diabetes","volume":"42","author":"Horsager","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.12.008_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mam.2015.09.003","article-title":"Molecular pathophysiology of hepatic glucose production","volume":"46","author":"Sharabi","year":"2015","journal-title":"Mol Aspect Med"},{"key":"10.1016\/j.clnu.2023.12.008_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrendo.2017.80","article-title":"Regulation of hepatic glucose metabolism in health and disease","volume":"13","author":"Petersen","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"7436","key":"10.1016\/j.clnu.2023.12.008_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.clnu.2023.12.008_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.clnu.2023.12.008_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/taap.1996.8029","article-title":"Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology","volume":"142","author":"Merrill","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"issue":"29","key":"10.1016\/j.clnu.2023.12.008_bib7","doi-asserted-by":"crossref","first-page":"25843","DOI":"10.1074\/jbc.R200009200","article-title":"De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway","volume":"277","author":"Merrill","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.clnu.2023.12.008_bib8","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.celrep.2017.02.019","article-title":"Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans","volume":"18","author":"Wigger","year":"2017","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.clnu.2023.12.008_bib9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"6451","key":"10.1016\/j.clnu.2023.12.008_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.aav3722","article-title":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.clnu.2023.12.008_bib11","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1038\/sj.emboj.7601715","article-title":"Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression","volume":"26","author":"Ravnskjaer","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.clnu.2023.12.008_bib12","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1038\/sj.emboj.7601734","article-title":"Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms","volume":"26","author":"Xu","year":"2007","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.clnu.2023.12.008_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: sensors for hormonal and metabolic signalings","volume":"12","author":"Altarejos","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.clnu.2023.12.008_bib14","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1073\/pnas.0914897107","article-title":"Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.clnu.2023.12.008_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s12276-022-00766-4","article-title":"Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response","volume":"54","author":"Kim","year":"2022","journal-title":"Exp Mol Med"},{"issue":"10","key":"10.1016\/j.clnu.2023.12.008_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides - lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol Metabol"},{"issue":"8","key":"10.1016\/j.clnu.2023.12.008_bib17","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2023.12.008_bib18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clnu.2023.12.008_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metabol"},{"key":"10.1016\/j.clnu.2023.12.008_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2018.12.046","article-title":"Circulating sphingolipids, fasting glucose, and impaired fasting glucose: the Strong Heart Family Study","volume":"41","author":"Jensen","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clnu.2023.12.008_bib21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/db17-1449","article-title":"Circulating sphingolipids, insulin, HOMA-IR, and HOMA-B: the strong heart family study","volume":"67","author":"Lemaitre","year":"2018","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.clnu.2023.12.008_bib22","first-page":"419","article-title":"Ceramide and sphingosine 1-phosphate in liver diseases","volume":"43","author":"Park","year":"2020","journal-title":"Mol Cell"},{"issue":"21","key":"10.1016\/j.clnu.2023.12.008_bib23","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1128\/MCB.23.21.7794-7808.2003","article-title":"Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)\/Akt by a PKCzeta-dependent mechanism","volume":"23","author":"Powell","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2023.12.008_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1463-1326.2011.01449.x","article-title":"The role of dysregulated glucagon secretion in type 2 diabetes","volume":"13","author":"D'Alessio","year":"2011","journal-title":"Diabetes Obes Metabol"},{"issue":"1","key":"10.1016\/j.clnu.2023.12.008_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI60016","article-title":"Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover","volume":"122","author":"Unger","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"7062","key":"10.1016\/j.clnu.2023.12.008_bib26","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature03967","article-title":"The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism","volume":"437","author":"Koo","year":"2005","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.clnu.2023.12.008_bib27","doi-asserted-by":"crossref","first-page":"15523","DOI":"10.1016\/S0021-9258(18)82288-8","article-title":"Ceramide activates heterotrimeric protein phosphatase 2A","volume":"268","author":"Dobrowsky","year":"1993","journal-title":"J\u00a0Biol Chem"},{"issue":"21","key":"10.1016\/j.clnu.2023.12.008_bib28","doi-asserted-by":"crossref","first-page":"12808","DOI":"10.1074\/jbc.270.21.12808","article-title":"The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2-ceramide","volume":"270","author":"Law","year":"1995","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.clnu.2023.12.008_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/jpet.108.147009","article-title":"Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys","volume":"329","author":"Yan","year":"2009","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"8","key":"10.1016\/j.clnu.2023.12.008_bib30","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/en.2015-1011","article-title":"Glucagon receptor blockade with a human antibody normalizes blood glucose in diabetic mice and monkeys","volume":"156","author":"Okamoto","year":"2015","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.clnu.2023.12.008_bib31","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2337\/dci15-0033","article-title":"Clinical trials, triumphs, and tribulations of glucagon receptor antagonists","volume":"39","author":"Pearson","year":"2016","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.clnu.2023.12.008_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.12997\/jla.2020.9.2.291","article-title":"Hepatic expression of the serine palmitoyltransferase subunit Sptlc2 reduces lipid droplets in the liver by activating VLDL secretion","volume":"9","author":"Kim","year":"2020","journal-title":"J\u00a0Lipid Atheroscler"},{"issue":"11","key":"10.1016\/j.clnu.2023.12.008_bib33","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s00125-017-4401-5","article-title":"VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells","volume":"60","author":"Botteri","year":"2017","journal-title":"Diabetologia"},{"issue":"16","key":"10.1016\/j.clnu.2023.12.008_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.166905","article-title":"Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production","volume":"8","author":"Yildirim","year":"2023","journal-title":"JCI Insight"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423004302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423004302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:15:07Z","timestamp":1759367707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561423004302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0261561423004302"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2023.12.008","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceramide enhanced the hepatic glucagon response through regulation of CREB activity","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2023.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}